Provided by Tiger Trade Technology Pte. Ltd.

Inhibikase Therapeutics, Inc.

2.38
+0.06502.81%
Volume:145.42K
Turnover:336.70K
Market Cap:332.50M
PE:-5.49
High:2.38
Open:2.30
Low:2.27
Close:2.31
52wk High:2.54
52wk Low:1.33
Shares:140.00M
Float Shares:64.52M
Volume Ratio:1.49
T/O Rate:0.23%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.4327
EPS(LYR):-0.4909
ROE:-51.96%
ROA:-32.79%
PB:2.17
PE(LYR):-4.84

Loading ...

Feb 24, 2025

Major Issues Report

Form 8-K - Current report
Feb 18, 2025

Major Issues Report

Form 8-K - Current report
Feb 04, 2025

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Jan 29, 2025

Major Issues Report

Form 8-K - Current report
Jan 14, 2025

Correspondence

Form CORRESP - Correspondence
Jan 06, 2025

Major Issues Report

Form 8-K - Current report
Dec 05, 2024

Major Issues Report

Form 8-K - Current report
Dec 03, 2024

Correspondence

Form CORRESP - Correspondence
Nov 14, 2024

Beneficial Ownership Change

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Nov 14, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Oct 28, 2024

Beneficial Ownership Change

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Oct 28, 2024

Beneficial Ownership Change

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Oct 25, 2024

Beneficial Ownership Change

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Oct 22, 2024

Beneficial Ownership Change

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Oct 22, 2024

Major Issues Report

Form 8-K - Current report
Oct 17, 2024

Beneficial Ownership Change

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Oct 17, 2024

Beneficial Ownership Change

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Oct 10, 2024

Major Issues Report

Form 8-K - Current report
Oct 10, 2024

Beneficial Ownership Change

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Oct 09, 2024

Major Issues Report

Form 8-K - Current report